BindingDB Entry 50031199: Recent advances in the discovery of competitive protein tyrosine phosphatase 1B inhibitors for the treatment of diabetes, obesity, and cancer.

Name: BindingDB Entry 50031199: Recent advances in the discovery of competitive protein tyrosine phosphatase 1B inhibitors for the treatment of diabetes, obesity, and cancer.
Creator: BindingDB
Keywords: Protein-tyrosine phosphatase 1B, Receptor-type tyrosine-protein phosphatase beta (PTPβ), and T-cell protein-tyrosine phosphatase, Incyte Corporation, Affinity, 3. Good health

Research datakeyboard_double_arrow_right Dataset 01 Jan 2010 English Publisher:BindingDB

Authors: BindingDB;

doi: 10.7270/q28p60mb

BindingDB Entry 50031199: Recent advances in the discovery of competitive protein tyrosine phosphatase 1B inhibitors for the treatment of diabetes, obesity, and cancer.

- Summary
- Subjects
- Related research
  (2)
- Metrics

tips_and_updates
Recommended

Abstract

Small molecule binding data for protein Protein-tyrosine phosphatase 1B, Receptor-type tyrosine-protein phosphatase beta (PTPβ), and T-cell protein-tyrosine phosphatase, Uniprot P17706, P18031, and P23467

Keywords

Protein-tyrosine phosphatase 1B, Receptor-type tyrosine-protein phosphatase beta (PTPβ), and T-cell protein-tyrosine phosphatase, Incyte Corporation, Affinity

2 Research products, page 1 of 1

Recent Advances in the Discovery of Competitive Protein Tyrosine Phosphatase 1B Inhibitors for the Treatment of Diabetes, Obesity, and Cancer
2009IsDerivedFrom
BindingDB Entry 50037975: 5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases.
2012IsAmongTopNSimilarDocuments

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average

BindingDB Entry 50031199: Recent advances in the discovery of competitive protein tyrosine phosphatase 1B inhibitors for the treatment of diabetes, obesity, and cancer.

BindingDB Entry 50031199: Recent advances in the discovery of competitive protein tyrosine phosphatase 1B inhibitors for the treatment of diabetes, obesity, and cancer.

2 Research products, page 1 of 1

Recent Advances in the Discovery of Competitive Protein Tyrosine Phosphatase 1B Inhibitors for the Treatment of Diabetes, Obesity, and Cancer

BindingDB Entry 50037975: 5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases.